Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Dacomitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Pfizer Ireland Pharmaceuticals

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Pfizer Inc

    U.S.A
    BioAsia
    Not Confirmed
    arrow

    Pfizer Inc

    U.S.A
    arrow
    BioAsia
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Dacomitinib hydrate

    Registrant Name : Korea Pfizer Pharmaceutical Co., Ltd.

    Registration Date : 2020-02-13

    Registration Number : Number 87-27-ND

    Manufacturer Name : Pfizer Ireland Pharmaceutica...

    Manufacturer Address : Ringaskiddy Active Pharmaceutical Ingredient Plant, PO Box 140, Ringaskiddy, County C...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Looking for 1110813-31-4 / Dacomitinib API manufacturers, exporters & distributors?

    Dacomitinib manufacturers, exporters & distributors 1

    20

    PharmaCompass offers a list of Dacomitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dacomitinib manufacturer or Dacomitinib supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dacomitinib manufacturer or Dacomitinib supplier.

    PharmaCompass also assists you with knowing the Dacomitinib API Price utilized in the formulation of products. Dacomitinib API Price is not always fixed or binding as the Dacomitinib Price is obtained through a variety of data sources. The Dacomitinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

    API | Excipient name

    Dacomitinib

    Synonyms

    1110813-31-4, Pf-00299804, Pf299804, Dacomitinib (pf299804, pf299), Dacomitinib anhydrous, (2e)-n-[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide

    Cas Number

    1110813-31-4

    Unique Ingredient Identifier (UNII)

    2XJX250C20

    About Dacomitinib

    Dacomitinib, designed as (2E)-N-16-4-(piperidin-1-yl) but-2-enamide, is an oral highly selective quinazalone part of the second-generation tyrosine kinase inhibitors which are characterized by the irreversible binding at the ATP domain of the epidermal growth factor receptor family kinase domains. Dacomitinib was developed by Pfizer Inc and approved by the FDA on September 27, 2018. Some evidence in the literature suggests the therapeutic potential of dacomitinib in the epithelial ovarian cancer model, although further investigations are needed.

    Dacomitinib Manufacturers

    A Dacomitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dacomitinib, including repackagers and relabelers. The FDA regulates Dacomitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dacomitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Dacomitinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Dacomitinib Suppliers

    A Dacomitinib supplier is an individual or a company that provides Dacomitinib active pharmaceutical ingredient (API) or Dacomitinib finished formulations upon request. The Dacomitinib suppliers may include Dacomitinib API manufacturers, exporters, distributors and traders.

    click here to find a list of Dacomitinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Dacomitinib KDMF

    In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

    Pharmaceutical companies submit a Dacomitinib Drug Master File in Korea (Dacomitinib KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Dacomitinib. The MFDS reviews the Dacomitinib KDMF as part of the drug registration process and uses the information provided in the Dacomitinib KDMF to evaluate the safety and efficacy of the drug.

    After submitting a Dacomitinib KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Dacomitinib API can apply through the Korea Drug Master File (KDMF).

    click here to find a list of Dacomitinib suppliers with KDMF on PharmaCompass.

    Dacomitinib Manufacturers | Traders | Suppliers

    Dacomitinib Manufacturers, Traders, Suppliers 1
    50

    We have 1 companies offering Dacomitinib

    Get in contact with the supplier of your choice:

    1. Pfizer Inc
    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.